| abstract |
The present invention presents various molecules specific for SLE (systemic lupus erythematosus). The present invention also provides a method for measuring, monitoring and / or diagnosing SLE disease or the likelihood of progression to SLE disease based on this molecule. This diagnostic method can use human biological samples such as serum, blood or plasma to simply, quickly, accurately measure, monitor and / or diagnose SLE disease or the likelihood of progression to the disease. |